128 related articles for article (PubMed ID: 1689319)
1. Effects of transforming growth factor-beta on long-term human cord blood monocyte cultures.
Orcel P; Bielakoff J; De Vernejoul MC
J Cell Physiol; 1990 Feb; 142(2):293-8. PubMed ID: 1689319
[TBL] [Abstract][Full Text] [Related]
2. Formation of multinucleated cells with osteoclast precursor features in human cord monocytes cultures.
Orcel P; Bielakoff J; de Vernejoul MC
Anat Rec; 1990 Jan; 226(1):1-9. PubMed ID: 2297075
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta enhances calcitonin-induced cyclic AMP production and the number of calcitonin receptors in long-term cultures of human umbilical cord blood monocytes in the presence of 1,25-dihydroxycholecalciferol.
Mbalaviele G; Orcel P; Bouizar Z; Jullienne A; De Vernejoul MC
J Cell Physiol; 1992 Sep; 152(3):486-93. PubMed ID: 1324244
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway.
Lerner UH
J Bone Miner Res; 1996 Nov; 11(11):1628-39. PubMed ID: 8915770
[TBL] [Abstract][Full Text] [Related]
5. Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone.
Roux S; Quinn J; Pichaud F; Orcel P; Chastre E; Jullienne A; De Vernejoul MC
J Cell Physiol; 1996 Sep; 168(3):489-98. PubMed ID: 8816903
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting and stimulating effects of TGF-beta 1 on osteoclastic bone resorption in fetal mouse bone organ cultures.
Dieudonné SC; Foo P; van Zoelen EJ; Burger EH
J Bone Miner Res; 1991 May; 6(5):479-87. PubMed ID: 2068954
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta 1 functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms.
Turley JM; Falk LA; Ruscetti FW; Kasper JJ; Francomano T; Fu T; Bang OS; Birchenall-Roberts MC
Cell Growth Differ; 1996 Nov; 7(11):1535-44. PubMed ID: 8930403
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of transforming growth factor-beta and epidermal growth factor on the cell cycle of cultured rabbit articular chondrocytes.
Vivien D; Galéra P; Lebrun E; Loyau G; Pujol JP
J Cell Physiol; 1990 Jun; 143(3):534-45. PubMed ID: 2358472
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 inhibits formation of osteoclastlike cells in long-term human marrow cultures but is not a mediator of the inhibitory effects of transforming growth factor beta.
Chenu C; Kurihara N; Mundy GR; Roodman GD
J Bone Miner Res; 1990 Jul; 5(7):677-81. PubMed ID: 2396495
[TBL] [Abstract][Full Text] [Related]
11. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
Kasid A; Bell GI; Director EP
J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
[TBL] [Abstract][Full Text] [Related]
12. Regulation of RANKL-induced osteoclastic differentiation by vascular cells.
Tintut Y; Abedin M; Cho J; Choe A; Lim J; Demer LL
J Mol Cell Cardiol; 2005 Aug; 39(2):389-93. PubMed ID: 15893766
[TBL] [Abstract][Full Text] [Related]
13. Role of transforming growth factor-beta in bone remodeling.
Bonewald LF; Mundy GR
Clin Orthop Relat Res; 1990 Jan; (250):261-76. PubMed ID: 2403492
[TBL] [Abstract][Full Text] [Related]
14. Effects of interleukin 3 and of granulocyte-macrophage and macrophage colony stimulating factors on osteoclast differentiation from mouse hemopoietic tissue.
Hattersley G; Chambers TJ
J Cell Physiol; 1990 Jan; 142(1):201-9. PubMed ID: 2153687
[TBL] [Abstract][Full Text] [Related]
15. Selective induction of Fc gamma RIII on human monocytes by transforming growth factor-beta.
Welch GR; Wong HL; Wahl SM
J Immunol; 1990 May; 144(9):3444-8. PubMed ID: 2139455
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
[TBL] [Abstract][Full Text] [Related]
17. Effects of transforming growth factor beta and epidermal growth factor on cell proliferation and the formation of bone nodules in isolated fetal rat calvaria cells.
Antosz ME; Bellows CG; Aubin JE
J Cell Physiol; 1989 Aug; 140(2):386-95. PubMed ID: 2787326
[TBL] [Abstract][Full Text] [Related]
18. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
Hébert CD; Birnbaum LS
Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899
[TBL] [Abstract][Full Text] [Related]
19. [Effects of various growth factors and hormones on clonal rat pulp cells].
Liang RF
Meikai Daigaku Shigaku Zasshi; 1990; 19(1):1-20. PubMed ID: 2134279
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta 1 selectively inhibits IL-3-dependent mast cell proliferation without affecting mast cell function or differentiation.
Broide DH; Wasserman SI; Alvaro-Gracia J; Zvaifler NJ; Firestein GS
J Immunol; 1989 Sep; 143(5):1591-7. PubMed ID: 2527268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
